93
Views
0
CrossRef citations to date
0
Altmetric
Editorial Article

The Natural Killer (NK) Cell and Synergistic Antitumor Effects of Interferon-Gamma and Interleukin-2

Pages 565-566 | Published online: 11 Jun 2009

References

  • Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131–136
  • Rubinstein M, Novick D, Fischer D G. The human interferon-γ receptor system. Immunol Rev 1987; 97: 29–50
  • Itoh K, Shiba K., Shiizu Y, et al. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL2) in collaboration with interferon-gamma (IFN-γ). J Immunol 1985; 134: 3124–3129
  • Findley H W, Jr, Nasr S, Afify Z, et al. Effects of recombinant interferon-gamma and interleukin 2 on the generation of lymphokine activated killer cells in vitro. Cancer Invest 1990; 8(4)000–000
  • Siegel J P, Sharon M, Smith P L, Leonard W J. The IL2 receptor chain (p70): role in mediating signals for LAK, NK and proliferative activities. Science 1987; 238: 75–78
  • Giovarelli M, Santoni A, Jemma C, et al. Obligatory role of IFN-γ in induction of lymphokine-activated and T lymphocyte killer activity but not in boosting of natural cytotoxicity. J Immunol 1988; 141: 2831–2836
  • Melder R J, Walker E R, Herberman R B, Whiteside T L. Surface characteristics, morphology and ultrastructure of human adherent lymphokine activated killer (A-LAK) cells. J Leukocyte Biol 1990, (in press)
  • Timonen T, Patarroyo M, Gahmberg C G. CD11a-c/CD18 and CP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol 1988; 141: 1041–1046
  • Anegon I, Cuturi M C, Trinchieri G, Perussia B. Interaction of Fc receptor (CD 16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988; 167: 452–472
  • Billiau A. Gamma-interferon: the match that lights the fire?. Immunol Today 1988; 9: 37–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.